Subarachnoid hemorrhage (SAH) associated with a ruptured cerebral aneurysm remains a source of significant morbidity and mortality, not only from the initial hemorrhage but also from the delayed complications, such as cerebral vasospasm often severe enough to induce irreversible changes in cerebral perfusion. Several drugs have been developed that have the potential to limit cerebral vasospasm and delayed ischemic neurologic deficit, thus improving outcome for patients.
Grasso, G., & Tomasello, F. (2012). Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?. WORLD NEUROSURGERY, 77(1), 46-48 [10.1016/j.wneu.2011.01.028].
Data di pubblicazione: | 2012 | |
Titolo: | Erythropoietin for subarachnoid hemorrhage: is there a reason for hope? | |
Autori: | ||
Citazione: | Grasso, G., & Tomasello, F. (2012). Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?. WORLD NEUROSURGERY, 77(1), 46-48 [10.1016/j.wneu.2011.01.028]. | |
Rivista: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.wneu.2011.01.028 | |
Abstract: | Subarachnoid hemorrhage (SAH) associated with a ruptured cerebral aneurysm remains a source of significant morbidity and mortality, not only from the initial hemorrhage but also from the delayed complications, such as cerebral vasospasm often severe enough to induce irreversible changes in cerebral perfusion. Several drugs have been developed that have the potential to limit cerebral vasospasm and delayed ischemic neurologic deficit, thus improving outcome for patients. | |
Settore Scientifico Disciplinare: | Settore MED/27 - Neurochirurgia | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Erythropoietin for subarachnoid.pdf | N/A | Administrator Richiedi una copia |